مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

531
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Radiolabeling and Biological Evaluation of 153Sm and 175Yb Zoledronic Acid Complexes

Pages

  52-61

Abstract

 Production of Bone pain palliation agents is developing increasingly for handling end-stage cancer patients. 153Sm and 175Yb labelled (1-hydroxy-2-imidazol-1-yl-phosphonoethyl) phosphoric acids can be used in bone pain palliation therapy. In this work, 153Sm and 175Yb labelled zoledronates were prepared using the commercial zoledronate ligand and 153SmCl3 and 175YbCl3 at 60º C, respectively. 153Sm Cl3 and 175YbCl3 were obtained by thermal neutron irradiation (4×1013 n. cm-2s-1) of the natural metal oxide samples. The radiochemical purities were checked by the instant thin layer chromatography (ITLC) and high performance liquid chromatography (HPLC) methods. The stability studies of the final preparations in the presence of human serum, as well as, hydroxyapatite (HA) binding test were performed (>97%). The Biodistribution of 153Sm and 153Sm-zoledronate performed in 2-48 h and for 175Yb and the 175Yb-zoledronate performed in 2-96 h post injection in the Syrian mice. The maximum bone uptake for 153Sm-zoledronate was 4% (48 h), while for 175Yb-zoledronate it was 10% (48 h). The complexes demonstrated satisfactory stability in the presence of human serum and the final formulations. However, the complexes are not appropriate for human studies due to the high liver uptake, possibly due to release of free metal from the complex and/or colloid formation.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Aghanejad, a., VAHIDFAR, N., JALILIAN, A.R., BAHRAMI SAMANI, A., MORADKHANI, S., & ERFANI, M.. (2016). Radiolabeling and Biological Evaluation of 153Sm and 175Yb Zoledronic Acid Complexes. JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, -(75 ), 52-61. SID. https://sid.ir/paper/97733/en

    Vancouver: Copy

    Aghanejad a., VAHIDFAR N., JALILIAN A.R., BAHRAMI SAMANI A., MORADKHANI S., ERFANI M.. Radiolabeling and Biological Evaluation of 153Sm and 175Yb Zoledronic Acid Complexes. JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY[Internet]. 2016;-(75 ):52-61. Available from: https://sid.ir/paper/97733/en

    IEEE: Copy

    a. Aghanejad, N. VAHIDFAR, A.R. JALILIAN, A. BAHRAMI SAMANI, S. MORADKHANI, and M. ERFANI, “Radiolabeling and Biological Evaluation of 153Sm and 175Yb Zoledronic Acid Complexes,” JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, vol. -, no. 75 , pp. 52–61, 2016, [Online]. Available: https://sid.ir/paper/97733/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button